MIM
FLGT icon

Macroview Investment Management’s Fulgent Genetics FLGT Stock Holding History

Macroview Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$371 – 823
2023
Q2 		$371 Hold
10
– – ﹤0.01% 456
2023
Q1 		$313 Hold
10
– – ﹤0.01% 422
2022
Q4 		$298 Hold
10
– – ﹤0.01% 432
2022
Q3 		$0 Hold
10
– – ﹤0.01% 446
2022
Q2 		$1K Hold
10
– – ﹤0.01% 393
2022
Q1 		$1K Hold
10
– – ﹤0.01% 378
2021
Q4 		$1K Hold
10
– – ﹤0.01% 347
2021
Q3 		$1K Hold
10
– – ﹤0.01% 339
2021
Q2 		$1K Hold
10
– – ﹤0.01% 365
2021
Q1 		$1K Sell
10
-5
-33% -$516 ﹤0.01% 340
2020
Q4 		$1K Buy
15
+5
+50% +$209 ﹤0.01% 315
2020
Q3 		$0 Buy
+10
New +$313 ﹤0.01% 340

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Macroview Investment Management's FLGT Position: Q3 2023 in Review

Macroview Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 10 shares — an estimated $371 sold.

Macroview Investment Management first reported a position in FLGT in Q3 2020 and held it in 12 quarters. The position peaked at $1K in Q2 2022. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • Macroview Investment Management reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • Macroview Investment Management sold 10 Fulgent Genetics shares in Q3 2023, an estimated $371.
  • Macroview Investment Management first reported a position in Fulgent Genetics in Q3 2020 and held it in 12 quarters.
  • Macroview Investment Management's Fulgent Genetics position peaked at $1K in Q2 2022.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Macroview Investment Management's 13F filing for Q3 2023, filed 26 Oct 2023.